These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19534)

  • 41. Induction of autoimmune phenomena in normal mice treated with natural thymocytotoxic autoantibody.
    Nakanishi A; Imai Y; Nakano T; Osawa T
    J Immunol; 1982 May; 128(5):2137-41. PubMed ID: 6460818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of disparate histocompatibility barriers in congenic strains of mice. II. Antibody-associated suppression.
    Cantrell JL; Hildemann WH
    J Immunol; 1973 Mar; 110(3):629-36. PubMed ID: 4143981
    [No Abstract]   [Full Text] [Related]  

  • 43. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 44. Selective thymus-derived cell enrichment in the rat spleen as a result of immunodepression by urethan.
    Di Marco AT; Franceschi C; Prodi G
    Cancer Res; 1972 Jul; 32(7):1569-73. PubMed ID: 4402277
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence for an abnormal microenvironment in the thymus of New Zealand black mice.
    Dauphinée MJ; Palmer DW; Talal N
    J Immunol; 1975 Oct; 115(4):1054-9. PubMed ID: 1100721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 48. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J; Stiller RA
    J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory mechanisms in cell-mediated immune responses. III. Antigen-specific and nonspecific suppressor activities generated during MLC.
    Hodes RJ; Nadler LM; Hathcock KS
    J Immunol; 1977 Sep; 119(3):961-7. PubMed ID: 70480
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization of the suppressor cell generated in a murine graft-versus-host reaction (GVHR).
    Shand FL
    Transplant Proc; 1977 Mar; 9(1):277-9. PubMed ID: 17194
    [No Abstract]   [Full Text] [Related]  

  • 52. Elimination of suppressor T-cells in mice undergoing a graft-versus-host reaction expressed by increased response to polyvinylpyrrolidone (PVP).
    Rotter V; Trainin N
    Cell Immunol; 1975 Jul; 18(1):199-209. PubMed ID: 237632
    [No Abstract]   [Full Text] [Related]  

  • 53. Depressed T-cell reactivity and suppressor activity of lymoid cells from cyclophosphamide-treated mice.
    Milton JD; Carpenter CB; Addison IE
    Cell Immunol; 1976 Jun; 24(2):308-17. PubMed ID: 779975
    [No Abstract]   [Full Text] [Related]  

  • 54. Graft-versus-Host reactions: a review.
    Grebe SC; Streilein JW
    Adv Immunol; 1976; 22():119-221. PubMed ID: 56872
    [No Abstract]   [Full Text] [Related]  

  • 55. Study of the multiple factors in the pathogenesis of autoimmunity in New Zealand mice.
    Steinberg AD; Klassen LW; Raveche ES; Gerber NL; Reinertsen JL; Krakauer RS; Ranney DF; Gershwin ME; Williams GW; Kovacs K; Reeves JP
    Arthritis Rheum; 1978 Jun; 21(5 Suppl):S190-201. PubMed ID: 27199
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of concanavalin A on immunologic abnormalities of New Zealand (NZB/W) mice.
    Gershwin ME; Steinberg AD
    Int Arch Allergy Appl Immunol; 1975; 48(2):220-4. PubMed ID: 1090540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Graft-versus-host induced immunosuppression associated with an increased thymic mitogen response.
    Lapp WS; Kirchner H
    Adv Exp Med Biol; 1979; 114():439-44. PubMed ID: 37717
    [No Abstract]   [Full Text] [Related]  

  • 59. Some effects thymocyte-stimulating factor.
    Chen DM; Sabato GD
    Cell Immunol; 1977 May; 30(2):195-203. PubMed ID: 16698
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathogenesis of autoimmunity in New Zealand mice. V. Loss of thymic suppressor function.
    Steinberg AD
    Arthritis Rheum; 1974; 17(1):11-4. PubMed ID: 4149328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.